Revolution Medicines, Inc.
RVMD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 16 sales; 693 institutions reported holding it in 13F filings for Q2 2026, worth $40.1B in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesRVMDW
13F holders, Q2 2021
Institutional positions in Revolution Medicines, Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 130
- +2 vs. Q1 2021
- Shares held
- 70.4M
- +3.91M (+5.9%) vs. Q1 2021
- Total value
- $2.23B
- −$815.7M (−26.8%) vs. Q1 2021
- New holders
- 20
- 64 more added
- Sold out
- 18
- 19 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 693 | $40.1B |
| Q1 2026 | 514 | $19.1B |
| Q4 2025 | 387 | $15.9B |
| Q3 2025 | 323 | $8.96B |
| Q2 2025 | 308 | $7.02B |
| Q1 2025 | 284 | $6.83B |
| Q4 2024 | 281 | $8.45B |
| Q3 2024 | 255 | $7.74B |
| Q2 2024 | 223 | $6.54B |
| Q1 2024 | 210 | $5.18B |
| Q4 2023 | 184 | $4.59B |
| Q3 2023 | 168 | $3.11B |
| Q2 2023 | 139 | $2.99B |
| Q1 2023 | 152 | $2.34B |
| Q4 2022 | 135 | $2.10B |
| Q3 2022 | 142 | $1.74B |
| Q2 2022 | 135 | $1.49B |
| Q1 2022 | 126 | $1.89B |
| Q4 2021 | 117 | $1.85B |
| Q3 2021 | 114 | $1.99B |
| Q2 2021 | 130 | $2.23B |
| Q1 2021 | 128 | $3.05B |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Revolution Medicines, Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nuveen Asset Management, LLC | 369,980 | $11.7M | 0.00% | +162,602+78.4% | Added |
| Candriam Luxembourg S.C.A. | 394,070 | $12.5M | 0.09% | +394,060+3,940,600.0% | Added |
| Blackstone Group Inc. | 416,629 | $13.2M | 0.03% | +416,629 | New |
| Bessemer Group Inc | 438,054 | $13.9M | 0.03% | 00.0% | Unchanged |
| Morgan Stanley | 526,418 | $16.7M | 0.00% | +367,073+230.4% | Added |
| Northern Trust Corp | 565,915 | $18.0M | 0.00% | +94,062+19.9% | Added |
| Harvard Management Co Inc | 670,382 | $21.3M | 1.22% | 00.0% | Unchanged |
| Ponoi Management, LLC | 685,011 | $21.7M | 12.08% | 00.0% | Unchanged |
| Ponoi II Management, LLC | 685,011 | $21.7M | 17.62% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 704,257 | $22.4M | 0.01% | −2,434−0.3% | Reduced |
| Woodline Partners LP | 851,592 | $27.0M | 0.50% | +9,530+1.1% | Added |
| Ameriprise Financial Inc | 937,485 | $29.7M | 0.01% | +517,478+123.2% | Added |
| Geode Capital Management, LLC | 944,058 | $30.0M | 0.00% | +165,458+21.3% | Added |
| Capital World Investors | 1,228,000 | $39.0M | 0.01% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 1,385,535 | $44.0M | 0.01% | +149,364+12.1% | Added |
| TRV GP IV, LLC | 1,419,900 | $45.1M | 21.46% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 1,565,712 | $49.7M | 0.88% | +129,000+9.0% | Added |
| Bellevue Group AG | 1,854,805 | $58.9M | 0.57% | +789,035+74.0% | Added |
| Casdin Capital, LLC | 2,305,000 | $73.2M | 1.86% | +460,465+25.0% | Added |
| State Street Corp | 2,348,590 | $74.5M | 0.00% | +570,410+32.1% | Added |
| BVF Inc | 2,485,049 | $78.9M | 2.96% | −458,000−15.6% | Reduced |
| Farallon Capital Management, L.L.C. | 2,500,000 | $79.3M | 0.38% | +890,270+55.3% | Added |
| Cormorant Asset Management, LP | 3,338,166 | $106.0M | 4.13% | +813,166+32.2% | Added |
| The Column Group LLC | 3,347,245 | $106.2M | 15.04% | −233,007−6.5% | Reduced |
| Boxer Capital, LLC | 3,484,264 | $110.6M | 3.90% | 00.0% | Unchanged |
| BlackRock Inc. | 4,818,130 | $152.9M | 0.00% | +987,056+25.8% | Added |
| Vanguard Group Inc | 5,268,564 | $167.2M | 0.00% | +418,302+8.6% | Added |
| TRV GP III, LLC | 5,524,031 | $175.3M | 30.61% | 00.0% | Unchanged |
| Wellington Management Group LLP | 5,579,048 | $177.1M | 0.03% | +1,658,400+42.3% | Added |
| FMR LLC | 9,534,259 | $302.6M | 0.02% | −1,297,986−12.0% | Reduced |
| TRV GP II, LLC | 0 | $0 | 0.00% | −1,909,317−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −205,788−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −75,902−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −34,012−100.0% | Sold out |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −32,413−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Copernicus Capital Management, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| SG Americas Securities, LLC | 0 | $0 | 0.00% | −9,813−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −8,662−100.0% | Sold out |
| Athanor Capital, LP | 0 | $0 | 0.00% | −8,107−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −7,122−100.0% | Sold out |
| Moloney Securities Asset Management, LLC | 0 | $0 | 0.00% | −4,500−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −2,994−100.0% | Sold out |
| Pacer Advisors, Inc. | 0 | $0 | 0.00% | −1,630−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −1,593−100.0% | Sold out |
| Eaton Vance Management | 0 | $0 | 0.00% | −126−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −125−100.0% | Sold out |
| Sargent Bickham Lagudis LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |